Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Advaxis, Inc.
Genmab
Revolution Medicines, Inc.
VA Office of Research and Development
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Duke University
Merck KGaA, Darmstadt, Germany
Genmab
M.D. Anderson Cancer Center
AstraZeneca